STAT+: FDA warns of security vulnerability in Illumina’s DNA sequencing machines

The Food and Drug Administration warned health care providers Thursday that a security vulnerability in DNA sequencers made by Illumina could allow unauthorized users to access or alter potentially important medical data.

The news is an embarrassing development at a time when Illumina’s management team, including CEO Francis deSouza, is trying to fight off a proxy battle by Carl Icahn. The activist investor is seeking to add three new members to Illumina’s board and has said that he would like to remove deSouza as CEO. 

Continue to STAT+ to read the full story…

Click here to view original post